The Healthpeak Properties Dilemma: Merger Payoff Ahead, Or More Pain For Investors?
DOC is a hold—stock trades near lows, post-merger integration is ongoing, and the market isn't buying the growth story yet. Merger with Physicians Realty Trust brings scale and diversification, but organic growth is lacking and integration risks remain. Valuation isn't compelling: payout ratio is stretched, margins are middling, and peers offer better value or growth opportunities.
Healthpeak: An Attractive Deal Here
Healthpeak Properties is trading at historically low valuations, offering a compelling 7% dividend yield with strong coverage and solid operating results. The REIT's diversified portfolio, consistent NOI growth, and defensive healthcare focus provide stability and resilience against macroeconomic shocks. Insider buying and share repurchases signal management's confidence in the stock's undervaluation and future upside potential.
5 Goldman Sachs S&P 500 Dividend Picks With the Highest Prospective Risk-Adjusted Returns
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.
Dividends Under $60: Don't Miss This 7.1% High-Yield Stock
A dividend stock with 7%-plus yields and solid upside potential. The downside risk is also limited at current prices.
5 Lessons For My 5 Kids
Fifteen years of investing and writing taught me that humility, perseverance, and financial literacy are essential for long-term success. Avoid market timing and emotional investing; focus on time in the market, sound fundamentals, and disciplined research-based decisions. Steer clear of high-yield, speculative REITs; prioritize blue-chip REITs with reliable income and growth prospects for wealth building.
3 Dividend Stocks That Could Double Your Monthly Income
Dividend stocks are worth loading up on, as significant uncertainty is still ahead.
Here's Why Healthpeak (DOC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthpeak's Q1 FFO Meets Estimates, Same-Store NOI Rises
DOC's Q1 results reflect the continued strong performance of its high-quality lab, outpatient medical and CCRC portfolios.
Here's What Key Metrics Tell Us About Healthpeak (DOC) Q1 Earnings
The headline numbers for Healthpeak (DOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthpeak (DOC) Q1 FFO Meet Estimates
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.45 per share a year ago.
What's in the Cards for Healthpeak Properties This Earnings Season?
DOC's Q1 earnings are likely to have benefited from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Countdown to Healthpeak (DOC) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Healthpeak (DOC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
